These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9822920

  • 21. Combination with CK19 Might Increase the Prognostic Power of Hep Par 1 in Hepatocellular Carcinoma after Curative Resection.
    Jin Y, Liang ZY, Zhou WX, Zhou L.
    J Invest Surg; 2018 Oct; 31(5):412-419. PubMed ID: 28758812
    [Abstract] [Full Text] [Related]

  • 22. Immunohistochemical characterization of canine hyperplastic hepatic lesions and hepatocellular and biliary neoplasms with monoclonal antibody hepatocyte paraffin 1 and a monoclonal antibody to cytokeratin 7.
    Ramos-Vara JA, Miller MA, Johnson GC.
    Vet Pathol; 2001 Nov; 38(6):636-43. PubMed ID: 11732796
    [Abstract] [Full Text] [Related]

  • 23. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
    Tsuji M, Kashihara T, Terada N, Mori H.
    Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850
    [Abstract] [Full Text] [Related]

  • 24. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.
    Terracciano LM, Glatz K, Mhawech P, Vasei M, Lehmann FS, Vecchione R, Tornillo L.
    Am J Surg Pathol; 2003 Oct; 27(10):1302-12. PubMed ID: 14508391
    [Abstract] [Full Text] [Related]

  • 25. Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.
    Tickoo SK, Zee SY, Obiekwe S, Xiao H, Koea J, Robiou C, Blumgart LH, Jarnagin W, Ladanyi M, Klimstra DS.
    Am J Surg Pathol; 2002 Aug; 26(8):989-97. PubMed ID: 12170085
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases.
    Atta IS.
    Histol Histopathol; 2021 Sep; 36(9):981-993. PubMed ID: 34254284
    [Abstract] [Full Text] [Related]

  • 27. Cytokeratin 20-positive hepatocellular carcinoma.
    Fanni D, Nemolato S, Ganga R, Senes G, Gerosa C, Van Eyken P, Geboes K, Faa G.
    Eur J Histochem; 2009 Dec 29; 53(4):e32. PubMed ID: 22073364
    [Abstract] [Full Text] [Related]

  • 28. Immunohistochemical detection of breast specific antigens and cytokeratins in metastatic breast carcinoma in the liver.
    Akasofu M, Kawahara E, Kurumaya H, Nakanishi I.
    Acta Pathol Jpn; 1993 Dec 29; 43(12):736-44. PubMed ID: 7509105
    [Abstract] [Full Text] [Related]

  • 29. Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report.
    Tanaka K, Honna T, Kitano Y, Kuroda T, Tanaka K, Morikawa N, Matsuda H, Kawashima N, Matsuoka K, Miyauchi J.
    J Clin Pathol; 2005 Aug 29; 58(8):884-7. PubMed ID: 16049296
    [Abstract] [Full Text] [Related]

  • 30. [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma].
    Dong H, Cong WL, Zhu ZZ, Wang B, Xian ZH, Yu H.
    Zhonghua Zhong Liu Za Zhi; 2008 Sep 29; 30(9):702-5. PubMed ID: 19173916
    [Abstract] [Full Text] [Related]

  • 31. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma.
    Xiao SY, Wang HL, Hart J, Fleming D, Beard MR.
    Am J Pathol; 2001 Oct 29; 159(4):1415-21. PubMed ID: 11583969
    [Abstract] [Full Text] [Related]

  • 32. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT.
    Cancer; 2001 Oct 25; 93(5):330-6. PubMed ID: 11668468
    [Abstract] [Full Text] [Related]

  • 33. A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.
    Fu X, Tan L, Liu S, Li H, Chen L, Qin J, Wu M, Wang H.
    J Cancer Res Clin Oncol; 2004 Sep 25; 130(9):514-20. PubMed ID: 15221469
    [Abstract] [Full Text] [Related]

  • 34. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.
    Tomimatsu M, Ishiguro N, Taniai M, Okuda H, Saito A, Obata H, Yamamoto M, Takasaki K, Nakano M.
    Cancer; 1993 Aug 01; 72(3):683-8. PubMed ID: 8192727
    [Abstract] [Full Text] [Related]

  • 35. MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers.
    Proca DM, Niemann TH, Porcell AI, DeYoung BR.
    Appl Immunohistochem Mol Morphol; 2000 Jun 01; 8(2):120-5. PubMed ID: 10937059
    [Abstract] [Full Text] [Related]

  • 36. The utility of estrogen receptor and progesterone receptor immunohistochemistry in the distinction of metastatic breast carcinoma from other tumors in the liver.
    Nash JW, Morrison C, Frankel WL.
    Arch Pathol Lab Med; 2003 Dec 01; 127(12):1591-5. PubMed ID: 14632573
    [Abstract] [Full Text] [Related]

  • 37. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis.
    Rullier A, Le Bail B, Fawaz R, Blanc JF, Saric J, Bioulac-Sage P.
    Am J Surg Pathol; 2000 Jun 01; 24(6):870-6. PubMed ID: 10843291
    [Abstract] [Full Text] [Related]

  • 38. Diagnostic significance of aquaporin-1 in liver tumors.
    Mazal PR, Susani M, Wrba F, Haitel A.
    Hum Pathol; 2005 Nov 01; 36(11):1226-31. PubMed ID: 16260277
    [Abstract] [Full Text] [Related]

  • 39. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
    Geramizadeh B, Boub R, Rahsaz M.
    Indian J Pathol Microbiol; 2007 Jul 01; 50(3):507-10. PubMed ID: 17883119
    [Abstract] [Full Text] [Related]

  • 40. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C, Marsh W, Frankel WL.
    Mod Pathol; 2002 Dec 01; 15(12):1279-87. PubMed ID: 12481008
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.